Literature DB >> 9259373

Mapping of a disease locus for familial rapidly progressive frontotemporal dementia to chromosome 17q12-21.

S Froelich1, H Basun, C Forsell, L Lilius, K Axelman, A Andreadis, L Lannfelt.   

Abstract

Familial frontotemporal dementia (FTD) is a complex disorder with lack of distinctive histopathological markers found in other types of dementia. Most of the linkage reports from FTD families map the disease loci to chromosome 17q21-22. However, FTD is genetically heterogeneous, as linkage also has been reported to chromosome 3. In the present study, we investigated the genetics of a Swedish family with an early-onset type of rapidly progressive FTD, associated with muscular rigidity and akinetic movements. Neuropathological features such as severe frontal lobe degeneration, spongy changes, and gliosis were present in affected family members. We here report probable linkage to chromosome 17q12-21 with a maximum two-point lod score of 2.76 at theta = 0 for marker D17S806, and a peak multipoint lod score of 2.86 for the same marker. Linkage to chromosome 3 was excluded, as two-point lod scores of -2.79, and -2.27 at theta = 0.01 for markers D3S1603 and D3S1552, respectively, were obtained. Sequencing of the translated exons of a strong candidate gene in the linked region of chromosome 17, the tau gene, failed to identify any mutations segregating with the disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9259373     DOI: 10.1002/(sici)1096-8628(19970725)74:4<380::aid-ajmg8>3.0.co;2-t

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  9 in total

Review 1.  Antibody Therapeutics Targeting Aβ and Tau.

Authors:  Gilbert Gallardo; David M Holtzman
Journal:  Cold Spring Harb Perspect Med       Date:  2017-10-03       Impact factor: 6.915

Review 2.  FTD and ALS: a tale of two diseases.

Authors:  R Ferrari; D Kapogiannis; E D Huey; P Momeni
Journal:  Curr Alzheimer Res       Date:  2011-05       Impact factor: 3.498

Review 3.  The genetics of frontotemporal lobar degeneration.

Authors:  Rosa Rademakers; Mike Hutton
Journal:  Curr Neurol Neurosci Rep       Date:  2007-09       Impact factor: 5.081

4.  Frontotemporal dementia in a large Swedish family is caused by a progranulin null mutation.

Authors:  Lena Skoglund; RoseMarie Brundin; Tommie Olofsson; Hannu Kalimo; Sofie Ingvast; Elin S Blom; Vilmantas Giedraitis; Martin Ingelsson; Lars Lannfelt; Hans Basun; Anna Glaser
Journal:  Neurogenetics       Date:  2008-10-15       Impact factor: 2.660

5.  High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands.

Authors:  P Rizzu; J C Van Swieten; M Joosse; M Hasegawa; M Stevens; A Tibben; M F Niermeijer; M Hillebrand; R Ravid; B A Oostra; M Goedert; C M van Duijn; P Heutink
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

Review 6.  The molecular genetics and neuropathology of frontotemporal lobar degeneration: recent developments.

Authors:  Ian R A Mackenzie; Rosa Rademakers
Journal:  Neurogenetics       Date:  2007-09-06       Impact factor: 2.660

7.  Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17.

Authors:  L N Clark; P Poorkaj; Z Wszolek; D H Geschwind; Z S Nasreddine; B Miller; D Li; H Payami; F Awert; K Markopoulou; A Andreadis; I D'Souza; V M Lee; L Reed; J Q Trojanowski; V Zhukareva; T Bird; G Schellenberg; K C Wilhelmsen
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

Review 8.  Liquid-liquid phase separation of tau: From molecular biophysics to physiology and disease.

Authors:  Sandeep K Rai; Adriana Savastano; Priyanka Singh; Samrat Mukhopadhyay; Markus Zweckstetter
Journal:  Protein Sci       Date:  2021-05-14       Impact factor: 6.725

Review 9.  Phenotypic Heterogeneity of Monogenic Frontotemporal Dementia.

Authors:  Alberto Benussi; Alessandro Padovani; Barbara Borroni
Journal:  Front Aging Neurosci       Date:  2015-09-01       Impact factor: 5.750

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.